Voloridge Investment Management’s Iovance Biotherapeutics IOVA Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$3.59M	Buy	+1,022,780	New	+$3.27M	0.01%	739
2024 Q4	–	Sell	-109,953	Closed	-$1.03M	–	1271
2024 Q3	$1.03M	Sell	109,953 -2,381,706	-96%	-$22.6M	﹤0.01%	1018
2024 Q2	$20M	Sell	2,491,659 -1,002,525	-29%	-$10.7M	0.07%	369
2024 Q1	$51.8M	Buy	3,494,184 +2,511,104	+255%	+$29.2M	0.19%	152
2023 Q4	$7.99M	Buy	983,080 +782,656	+391%	+$4.1M	0.03%	522
2023 Q3	$912K	Sell	200,424 -329,718	-62%	-$2.15M	﹤0.01%	1116
2023 Q2	$3.73M	Sell	530,142 -598,771	-53%	-$4.29M	0.02%	777
2023 Q1	$6.9M	Sell	1,128,913 -581,929	-34%	-$4.01M	0.03%	568
2022 Q4	$10.9M	Buy	1,710,842 +267,794	+19%	+$2.09M	0.06%	405
2022 Q3	$13.8M	Buy	1,443,048 +437,941	+44%	+$5.05M	0.07%	356
2022 Q2	$11.1M	Buy	1,005,107 +259,895	+35%	+$3.41M	0.06%	406
2022 Q1	$12.4M	Buy	745,212 +141,536	+23%	+$2.19M	0.07%	351
2021 Q4	$11.5M	Sell	603,676 -34,758	-5%	-$765K	0.06%	425
2021 Q3	$15.7M	Sell	638,434 -55,183	-8%	-$1.3M	0.1%	273
2021 Q2	$18M	Buy	693,617 +609,506	+725%	+$15.8M	0.13%	213
2021 Q1	$2.66M	Buy	84,111 +47,800	+132%	+$1.98M	0.02%	716
2020 Q4	$1.69M	Buy	+36,311	New	+$1.44M	0.01%	797